Dr. Mitra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1545 Divisadero St
Second Floor
San Francisco, CA 94115Phone+1 415-353-7900Fax+1 415-353-2640- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2011 - 2014
- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2011
- University of California San Francisco School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- FPT155 in Patients With Advanced Solid Tumors Start of enrollment: 2018 Nov 14
Publications & Presentations
PubMed
- Author Correction: A Tunguska sized airburst destroyed Tall el-Hammam a Middle Bronze Age city in the Jordan Valley near the Dead Sea.Ted E Bunch, Malcolm A LeCompte, A Victor Adedeji, James H Wittke, T David Burleigh, Robert E Hermes, Charles Mooney, Dale Batchelor, Wendy S Wolbach, Joel Kathan, Gun...> ;Scientific Reports. 2023 May 22
- 43 citationsBemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 s...Zev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, Shukui Qin, Kensei Yamaguchi, In-Ho Kim, Anwaar Saeed, Sang Cheul Oh, Jin Li, Haci Mehmet Turk, Alexandra Teixeira, Ch...> ;The Lancet. Oncology. 2022 Nov 1
- 4 citationsMapping the tumor-infiltrating immune cells during glioblastoma progression.Senthilnath Lakshmanachetty, Siddhartha S Mitra> ;Nature Immunology. 2022 Jun 1
- Join now to see all
Journal Articles
- BMI1 Is a Therapeutic Target in Recurrent MedulloblastomaSiddhartha Mitra, MD, Nature
Press Mentions
- Drug Combination for Children with MYC Amplified MedulloblastomaJanuary 16th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: